Beijing Strong Biotechnologies Inc (300406) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.046x

Based on the latest financial reports, Beijing Strong Biotechnologies Inc (300406) has a cash flow conversion efficiency ratio of 0.046x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥182.86 Million ≈ $26.76 Million USD) by net assets (CN¥4.00 Billion ≈ $584.63 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see market cap of Beijing Strong Biotechnologies Inc for the company's overall valuation and market capitalisation.

Beijing Strong Biotechnologies Inc - Cash Flow Conversion Efficiency Trend (2011–2024)

This chart illustrates how Beijing Strong Biotechnologies Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Beijing Strong Biotechnologies Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Beijing Strong Biotechnologies Inc ranked by their cash flow conversion efficiency. Explore Beijing Strong Biotechnologies Inc (300406) cash earnings ratio to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
GuangYuYuan Chinese Herbal Medicine Co Ltd SHG:600771	0.065x
Pegavision TW:6491	0.067x
Shandong Bohui Paper Industry Co Ltd SHG:600966	0.177x
Shenzhen Sunshine Laser & Electronics Technology Co Ltd SHE:300227	-0.059x
Aksa Akrilik Kimya Sanayi AS IS:AKSA	0.004x
Canaccord Genuity Group Inc TO:CF	0.333x
Three Squirrels SHE:300783	0.001x
Smarter Microelectronics (Guangzhou) Co. Ltd. A SHG:688512	N/A

Annual Cash Flow Conversion Efficiency for Beijing Strong Biotechnologies Inc (2011–2024)

The table below shows the annual cash flow conversion efficiency of Beijing Strong Biotechnologies Inc from 2011 to 2024. View 300406 stock price and chart for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CN¥4.13 Billion ≈ $604.76 Million	CN¥614.01 Million ≈ $89.85 Million	0.149x	-6.31%
2023-12-31	CN¥3.72 Billion ≈ $544.58 Million	CN¥590.15 Million ≈ $86.36 Million	0.159x	+30.84%
2022-12-31	CN¥3.27 Billion ≈ $478.32 Million	CN¥396.17 Million ≈ $57.97 Million	0.121x	+3.52%
2021-12-31	CN¥2.91 Billion ≈ $426.32 Million	CN¥341.10 Million ≈ $49.91 Million	0.117x	+225.72%
2020-12-31	CN¥3.42 Billion ≈ $500.96 Million	CN¥123.06 Million ≈ $18.01 Million	0.036x	-62.44%
2019-12-31	CN¥1.97 Billion ≈ $288.41 Million	CN¥188.60 Million ≈ $27.60 Million	0.096x	-36.41%
2018-12-31	CN¥1.70 Billion ≈ $249.09 Million	CN¥256.15 Million ≈ $37.48 Million	0.150x	+10.74%
2017-12-31	CN¥1.53 Billion ≈ $223.89 Million	CN¥207.91 Million ≈ $30.42 Million	0.136x	-22.45%
2016-12-31	CN¥1.39 Billion ≈ $203.11 Million	CN¥243.21 Million ≈ $35.59 Million	0.175x	+44.42%
2015-12-31	CN¥1.18 Billion ≈ $171.97 Million	CN¥142.59 Million ≈ $20.86 Million	0.121x	-23.69%
2014-12-31	CN¥987.03 Million ≈ $144.43 Million	CN¥156.94 Million ≈ $22.97 Million	0.159x	-48.55%
2013-12-31	CN¥476.31 Million ≈ $69.70 Million	CN¥147.19 Million ≈ $21.54 Million	0.309x	-5.02%
2012-12-31	CN¥385.67 Million ≈ $56.44 Million	CN¥125.49 Million ≈ $18.36 Million	0.325x	+104.63%
2011-12-31	CN¥288.66 Million ≈ $42.24 Million	CN¥45.90 Million ≈ $6.72 Million	0.159x	--

About Beijing Strong Biotechnologies Inc

SHE:300406 China Diagnostics & Research

Market Cap

$967.77 Million

CN¥6.61 Billion CNY

Market Cap Rank

#9080 Global

#2232 in China

Share Price

CN¥11.28

Change (1 day)

+0.89%

52-Week Range

CN¥10.82 - CN¥15.23

All Time High

CN¥24.76